Skip to main content
. Author manuscript; available in PMC: 2021 Apr 1.
Published in final edited form as: Lancet Psychiatry. 2020 Jul 28;7(10):865–874. doi: 10.1016/S2215-0366(20)30290-X

Table 4.

Mean (95% Interval Estimates) plasma concentrations of CBD (ng/ml) stratified by group and time point in the Placebo (n=23), 200mg (n=12), 400mg (n=24) and 800mg (n=23) treatment arms

Placebo 200mg CBD 400mg CBD 800mg CBD
Week 0 0.12
(-0.01, 0.24)		 0.02
(-0.01, 0.06)		 0.15
(-0.06, 0.36)		 0.02
(-0.02, 0.07)
Week 2 0.06
(-0.03, 0.15)		 10.28
(4.20, 16.36)		 40.42
(19.12, 61.72)		 59.31
(17.95, 100.67)
Week 4 0.07
(0.00, 0.13)		 10.24
(2.65, 17.83)		 21.63
(11.06, 32.20)		 63.33
(30.09, 96.57)
Week 6 0.09
(-0.04, 0.21)		 0.49
(0.32, 0.66)		 4.14
(0.12, 8.16)		 3.91
(2.42, 5.41)
Week 12 0.02
(-0.03, 0.08)		 0.00
(0.00, 0.00)		 0.19
(0.06, 0.32)		 0.34
(0.14, 0.55)